Press Release for Financial Results For quarter ended Sep-25
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Deccan Health Care Limited reported strong Q2 and H1 FY26 results with standalone revenue of ₹2,440.46 lakh in Q2 (up 29.7% YoY) and ₹4,587.41 lakh in H1 (up 35.4% YoY). Standalone net profit jumped 67.5% YoY to ₹89.97 lakh in Q2, while H1 profit rose 22.8% YoY to ₹111.22 lakh. Consolidated revenue was ₹2,139.56 lakh in Q2 with a consolidated PAT of ₹91.40 lakh. The company expanded its wellness portfolio with new launches like EnergyDecc, SlimDecc, and a Weight Wellness Program, and is preparing UAE and GCC market entries by March 2026 after regulatory filings in six international markets. EPS is improving and the company reported zero investor complaints, reflecting strong governance and steady value accretion for shareholders.
Strong double-digit revenue and profit growth, a wider product pipeline, and international expansion plans point to positive momentum; however, the absolute size of the business remains small (standalone quarterly revenue under ₹25 crore) and forward-looking statements carry the usual risks around approvals and competition.